AC 2005 Vol-1.pdf - Cecmed - Infomed

24
Revisión sobre el factor...
[39] Hartung T, Gaviria JM, Garrido Sm, Root RK.
G-csf and GM-CSF In: Holland SM, editor.
Cytokine therapeutics in infectious diseases.
Philadelphia: Lippincott Williams and Wilkins,
185-220, 2001.
[40] Lieschke GJ, Burgess AW. Granulocyte colonystimulating
factor and granulocyte-macrophage
colony-stimulating factor (1 and 2). N Engl J
Med 327:28-35,99-106, 1992.
[41] Crawford J, Ozer H, Stoller R, Johnson D,
Lyman G, Tabbara I, et al. Reduction by
granulocyte colony-stimulating factor of fever
and neutropenia induced by chemotherapy in
patients with small-cell lung cancer. N Engl J
Med ;325:164-70, 1991.
[42] Pettengell R, Gurney H, Radford JA, Deakin DP,
James R,Wilkinson PM, et al. Granulocyte
colony-stimulating factor to prevent doselimiting
neutropenia in non-Hodgkin's
lymphoma: a randomized controlled trial. Blood,
80,1430-6, 1992.
[43] Trillet-Lenoir V, Green J, Manegold C, Von
Pawel J, Gatzemeier U, Lebeau B, et al.
Recombinant granulocyte colony stimulating
factor reduces the infectious complications of
cytotoxic chemotherapy. Eur J Cancer 29A:319-
24., 1993.
[44] Sheridan WP, Morstyn G, Wolf M, Dodds A,
Lusk J, Maher D, et al. Granulocyte colonystimulating
factor and neutrophil recovery after
high-dose chemotherapy and autologous bone
marrow transplantation. Lancet 2, 891-5, 1989.
[45] Gisselbrecht C, Prentice HG, Bacigalupo A,
Biron P, Milpied N, Rubie H, et al. Placebocontrolled
phase III trial of lenograstim in bonemarrow
transplantation. Lancet 343, 696-700,
1994.
[46] Dale DC, Bonilla MA, Davis MW, Nakanishi
AM, Hammond WP, Kurtzberg J, et al. A
randomized controlled phase III trial of
recombinant human granulocyte colonystimulating
factor (filgrastim) for treatment of
severe chronic neutropenia. Blood 81, 2496-502,
1993.
Recibido: 10 de septiembre de 2004
Aceptado: 20 de diciembre de 2004